## Neuromuscular Blockers in RSI: Succinylcholine vs. Rocuronium **Key Point:** Both succinylcholine and rocuronium are used in RSI, but they differ in pharmacology, onset, duration, and safety profile. The question asks which statement is INCORRECT. ### Comparison Table | Feature | Succinylcholine | Rocuronium | |---------|-----------------|------------| | **Onset** | 30–40 seconds | 60–90 seconds | | **Duration** | 5–10 minutes | 30–40 minutes | | **Mechanism** | Depolarizing | Non-depolarizing | | **Histamine release** | Yes (can cause anaphylaxis) | No | | **Hyperkalemia risk** | High (especially in burns, trauma, denervation) | Minimal | | **Pseudocholinesterase deficiency** | Prolonged paralysis | No effect | | **Anaphylaxis risk** | Yes (histamine + other mechanisms) | Rare (but possible) | ### Why Option 2 is Incorrect **High-Yield:** The statement claims rocuronium is "free from" anaphylaxis risk. This is **false**. While rocuronium does NOT cause histamine release, it can still trigger anaphylaxis through IgE-mediated mechanisms (quaternary ammonium group). Rocuronium has a **higher reported incidence of perioperative anaphylaxis** than succinylcholine in some populations, particularly in France and other European countries. **Clinical Pearl:** Rocuronium-induced anaphylaxis is a recognized complication, especially in patients with prior rocuronium exposure or atopy. The statement's claim that rocuronium is "free from" anaphylaxis risk is misleading and incorrect. ### Succinylcholine: Advantages & Disadvantages **Advantages:** - Rapid onset (ideal for RSI) - Short duration (allows rapid recovery if intubation fails) **Disadvantages:** - Histamine release → bronchospasm, hypotension, anaphylaxis - Hyperkalemia (especially in burns, crush injury, denervation, renal failure) - Malignant hyperthermia trigger - Pseudocholinesterase deficiency → prolonged paralysis - Increased intracranial pressure - Increased intraocular pressure ### Rocuronium: Advantages & Disadvantages **Advantages:** - No histamine release - No hyperkalemia risk - No malignant hyperthermia risk - Suitable for pseudocholinesterase deficiency **Disadvantages:** - Slower onset (60–90 seconds) — less ideal for RSI - Longer duration (30–40 minutes) - Can cause anaphylaxis (quaternary ammonium-mediated) - Requires reversal with sugammadex (rocuronium-specific reversal agent) **Mnemonic: CRASH-B (Succinylcholine Contraindications)** - **C** — Crush injury, Cardiac arrhythmias - **R** — Renal failure, Rhabdomyolysis - **A** — Atrophy, Anaphylaxis history - **S** — Spinal cord injury, Severe burns - **H** — Hyperkalemia risk, Hyperthermia (malignant) - **B** — Pseudocholinesterase deficiency (Butyrylcholinesterase) **Warning:** Do not assume rocuronium is anaphylaxis-free. It carries a documented risk, albeit through a different mechanism than succinylcholine.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.